Previous 10 |
home / stock / tbp:cc / tbp:cc news
Tetra Bio-Pharma and Cannvalate Enter Into Partnership Canada NewsWire Cannvalate to invest CAD$7.5M in Tetra. Cannvalate to launch and manage QIXLEEF™ and CAUMZ™ clinical trials in Australia . The Company to benefit from a 43.5% tax credi...
Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA Canada NewsWire The Type C meeting with the FDA provides guidance to strengthen QIXLEEF™ nonclinical and toxicological data package for marketing approval. OTTAWA, ON , ...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc. Company Name:
TBP:CC Stock Symbol:
TSXC Market:
Tetra Bio-Pharma Inc. Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...